Chemical Compound
DOLUTEGRAVIR SODIUM
CAS Registry Number
1051375-19-9
Primary Record
DOLUTEGRAVIR SODIUM
- In stock
- 5,263 g
- Purity
- 98.7 %
- CAS
- 1051375-19-9
Compound Identifiers & Properties
- CAS
- 1051375-19-9
- PubChem CID
- 46216142
- SMILES
- C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+]
- Canonical SMILES
- C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12.[Na+]
Names & Synonyms
- DOLUTEGRAVIR SODIUM
- Tivicay
- Dovato
- 1051375-19-9
- Dolutegravir
- Dolutegravir sodium salt
- Dolutegravir (sodium)
- Tivicay (TN)
- TIVICAY PD
- GSK1349572 sodium
- UNII-1Q1V9V5WYQ
- GSK1349572 sodiuM salt
- Dolutegravir sodium [USAN]
- 1Q1V9V5WYQ
- RefChem:56965
- Alendronate sodium hydrate
- GSK 1349572A
- C20H18F2N3NaO5
- CHEBI:76007
- Dolutegravir Sodium ( API)
- GSK-1349572A
- GSK1349572A
- Tivicay (Dolutegravir Sodium)
- MFCD28405599
- orb1305676
- CHEMBL1213165
- SCHEMBL19859120
- SCHEMBL29363090
- Dolutegravir sodium (JAN/USAN)
- DOLUTEGRAVIR SODIUM [JAN]
- DTXCID001513426
- DTXSID201027849
- GLXC-10568
- BCP11890
- EX-A1694
- DOLUTEGRAVIR SODIUM [WHO-DD]
- HY-13238A
- s4642
- DOLUTEGRAVIR SODIUM SALT [MI]
- AKOS025396662
- ACN-041354
- CS-3496
- GSK1349572
- JULUCA COMPONENT DOLUTEGRAVIR SODIUM
- KS-00000T34
- TRIUMEQ COMPONENT DOLUTEGRAVIR SODIUM
- DOLUTEGRAVIR SODIUM [ORANGE BOOK]
- AS-57143
- DA-62992
- B5856
- D10113
- A921951
- F799859
- sodium;(3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate
- Q27145679
- Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
- B2693-463509
- 2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZINE-9-CARBOXAMIDE, N-((2,4-DIFLUOROPHENYL)METHYL)-3,4,6,8,12,12A-HEXAHYDRO-7-HYDROXY-4-METHYL-6,8-DIOXO-, SODIUM SALT (1:1), (4R,12AS)-
- 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt (1:1), (4R,12aS)-; Dolutegravir sodium; Dolutegravir sodium salt; GSK 1349572A; GSK 1349572A
- DTG
- GSK1349572sodiuMsalt;DOLUTEGRAVIRSODIUM;GSK1349572A;Dolutegravir sodiuM salt;Dolutegravir SodiuM ( API)
- SODIUM (4R,12AS)-9-(((2,4-DIFLUOROPHENYL)METHYL)CARBAMOYL)-4-METHYL-6,8-DIOXO-3,4,6,8,12,12A-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZIN-7-OLATE
- Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate;Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
- sodium (4R,12aS)-9-[(2,4-difluorobenzyl)carbamoyl]-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate